A citation-based method for searching scientific literature

Saadet Inan, Alan Cowan. Handb Exp Pharmacol 2022
Times Cited: 8







List of co-cited articles
42 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Efficacy and safety of a novel ĸ-agonist for managing intractable pruritus in dialysis patients.
Hiroo Kumagai, Toshiya Ebata, Kenji Takamori, Katsumasa Miyasato, Taro Muramatsu, Hidetomo Nakamoto, Masanao Kurihara, Tomoji Yanagita, Hiromichi Suzuki. Am J Nephrol 2012
93
37

Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans.
S L Walsh, E C Strain, M E Abreu, G E Bigelow. Psychopharmacology (Berl) 2001
175
37

Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study.
Hiroo Kumagai, Toshiya Ebata, Kenji Takamori, Taro Muramatsu, Hidetomo Nakamoto, Hiromichi Suzuki. Nephrol Dial Transplant 2010
195
37

Psychotomimesis mediated by kappa opiate receptors.
A Pfeiffer, V Brantl, A Herz, H M Emrich. Science 1986
673
37

Clinical Profiles of Nalfurafine Hydrochloride for the Treatment of Pruritus Patients.
Yohei Miyamoto, Takanori Oh, Eiji Aihara, Akihiro Ando. Handb Exp Pharmacol 2022
7
42

Dynorphin acts as a neuromodulator to inhibit itch in the dorsal horn of the spinal cord.
Adam P Kardon, Erika Polgár, Junichi Hachisuka, Lindsey M Snyder, Darren Cameron, Sinead Savage, Xiaoyun Cai, Sergei Karnup, Christopher R Fan, Gregory M Hemenway,[...]. Neuron 2014
208
25

Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids.
Xian-Yu Liu, Zhong-Chun Liu, Yan-Gang Sun, Michael Ross, Seungil Kim, Feng-Fang Tsai, Qi-Fang Li, Joseph Jeffry, Ji-Young Kim, Horace H Loh,[...]. Cell 2011
187
25


Central opioid receptors mediate morphine-induced itch and chronic itch via disinhibition.
Zilong Wang, Changyu Jiang, Hongyu Yao, Ouyang Chen, Sreya Rahman, Yun Gu, Junli Zhao, Yul Huh, Ru-Rong Ji. Brain 2021
19
25

The changing opioid crisis: development, challenges and opportunities.
Nora D Volkow, Carlos Blanco. Mol Psychiatry 2021
78
25


New and emerging treatments for inflammatory itch.
Stephen Erickson, Aaron Ver Heul, Brian S Kim. Ann Allergy Asthma Immunol 2021
27
25

Itch: From mechanism to (novel) therapeutic approaches.
Gil Yosipovitch, Jordan Daniel Rosen, Takashi Hashimoto. J Allergy Clin Immunol 2018
119
25

Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders.
Moriah L Jacobson, Caroline A Browne, Irwin Lucki. Annu Rev Pharmacol Toxicol 2020
30
25

A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.
Steven Fishbane, Aamir Jamal, Catherine Munera, Warren Wen, Frédérique Menzaghi. N Engl J Med 2020
105
25


Kinase cascades and ligand-directed signaling at the kappa opioid receptor.
Michael R Bruchas, Charles Chavkin. Psychopharmacology (Berl) 2010
210
25

The Kappa Opioid Receptor System in Temporal Lobe Epilepsy.
Luca Zangrandi, Christoph Schwarzer. Handb Exp Pharmacol 2022
4
50

Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140).
Miguel Guerrero, Mariangela Urbano, Eun-Kyong Kim, Ana M Gamo, Sean Riley, Lusine Abgaryan, Nora Leaf, Lori Jean Van Orden, Steven J Brown, Jennifer Y Xie,[...]. J Med Chem 2019
19
25

Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist.
Yan Zhou, Kevin Freeman, Vincent Setola, Danni Cao, Shane Kaski, Mary Jeanne Kreek, Lee-Yuan Liu-Chen. Handb Exp Pharmacol 2022
4
50

Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?
A Albert-Vartanian, M R Boyd, A L Hall, S J Morgado, E Nguyen, V P H Nguyen, S P Patel, L J Russo, A J Shao, R B Raffa. J Clin Pharm Ther 2016
64
25

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
Bryan L Roth, Karen Baner, Richard Westkaemper, Daniel Siebert, Kenner C Rice, SeAnna Steinberg, Paul Ernsberger, Richard B Rothman. Proc Natl Acad Sci U S A 2002
562
25

Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders.
Brian Reed, Eduardo R Butelman, Mary Jeanne Kreek. Handb Exp Pharmacol 2022
6
33

Characterization of a Knock-In Mouse Line Expressing a Fusion Protein of κ Opioid Receptor Conjugated with tdTomato: 3-Dimensional Brain Imaging via CLARITY.
Chongguang Chen, Alex H Willhouse, Peng Huang, Nora Ko, Yujun Wang, Bin Xu, Lan Hsuan Melody Huang, Brigitte Kieffer, Mary F Barbe, Lee-Yuan Liu-Chen. eNeuro 2020
26
25

A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of JDTic.
Jeffrey J Buda, F I Carroll, Thomas R Kosten, Dennis Swearingen, Bradford B Walters. Neuropsychopharmacology 2015
35
25


Development of κ opioid receptor antagonists.
F Ivy Carroll, William A Carlezon. J Med Chem 2013
118
25


Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects.
Kelly F Paton, Diana V Atigari, Sophia Kaska, Thomas Prisinzano, Bronwyn M Kivell. J Pharmacol Exp Ther 2020
20
25

Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors.
Todd W Vanderah, Tally Largent-Milnes, Josephine Lai, Frank Porreca, Richard A Houghten, Frédérique Menzaghi, Kazimierz Wisniewski, Jacek Stalewski, Javier Sueiras-Diaz, Robert Galyean,[...]. Eur J Pharmacol 2008
81
25

The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo.
Kate L White, J Elliott Robinson, Hu Zhu, Jeffrey F DiBerto, Prabhakar R Polepally, Jordan K Zjawiony, David E Nichols, C J Malanga, Bryan L Roth. J Pharmacol Exp Ther 2015
132
25

Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain.
A C Pande, R E Pyke, M Greiner, G L Wideman, R Benjamin, M W Pierce. Clin Neuropharmacol 1996
59
25

Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Jonathan M Ehrich, Daniel I Messinger, Cerise R Knakal, Jamie R Kuhar, Selena S Schattauer, Michael R Bruchas, Larry S Zweifel, Brigitte L Kieffer, Paul E M Phillips, Charles Chavkin. J Neurosci 2015
107
25

Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.
Jeffrey J Liu, Yi-Ting Chiu, Kelly M DiMattio, Chongguang Chen, Peng Huang, Taylor A Gentile, John W Muschamp, Alan Cowan, Matthias Mann, Lee-Yuan Liu-Chen. Neuropsychopharmacology 2019
62
25

U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
P F Vonvoigtlander, R A Lahti, J H Ludens. J Pharmacol Exp Ther 1983
880
25

Potent antinociceptive effects of TRK-820, a novel kappa-opioid receptor agonist.
T Endoh, H Matsuura, A Tajima, N Izumimoto, C Tajima, T Suzuki, A Saitoh, T Suzuki, M Narita, L Tseng,[...]. Life Sci 1999
79
25

Comparison of Pharmacological Properties between the Kappa Opioid Receptor Agonist Nalfurafine and 42B, Its 3-Dehydroxy Analogue: Disconnect between in Vitro Agonist Bias and in Vivo Pharmacological Effects.
Danni Cao, Peng Huang, Yi-Ting Chiu, Chongguang Chen, Huiqun Wang, Mengchu Li, Yi Zheng, Frederick J Ehlert, Yan Zhang, Lee-Yuan Liu-Chen. ACS Chem Neurosci 2020
11
25

Fundamentals of the Dynorphins/Kappa Opioid Receptor System: From Distribution to Signaling and Function.
Catherine Cahill, Hugo A Tejeda, Mariana Spetea, Chongguang Chen, Lee-Yuan Liu-Chen. Handb Exp Pharmacol 2022
7
28

Molecular Genetics of Kappa Opioids in Pain and Itch Sensations.
Pang-Yen Tseng, Mark A Hoon. Handb Exp Pharmacol 2022
5
40

Mu opioids and their receptors: evolution of a concept.
Gavril W Pasternak, Ying-Xian Pan. Pharmacol Rev 2013
324
25

Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.
Aashish Manglik, Andrew C Kruse, Tong Sun Kobilka, Foon Sun Thian, Jesper M Mathiesen, Roger K Sunahara, Leonardo Pardo, William I Weis, Brian K Kobilka, Sébastien Granier. Nature 2012
955
25

Structure of the human κ-opioid receptor in complex with JDTic.
Huixian Wu, Daniel Wacker, Mauro Mileni, Vsevolod Katritch, Gye Won Han, Eyal Vardy, Wei Liu, Aaron A Thompson, Xi-Ping Huang, F Ivy Carroll,[...]. Nature 2012
658
25

Blocking microglial pannexin-1 channels alleviates morphine withdrawal in rodents.
Nicole E Burma, Robert P Bonin, Heather Leduc-Pessah, Corey Baimel, Zoe F Cairncross, Michael Mousseau, Jhenkruthi Vijaya Shankara, Patrick L Stemkowski, Dinara Baimoukhametova, Jaideep S Bains,[...]. Nat Med 2017
99
12


Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability.
Ziva D Cooper, Gillinder Bedi, Divya Ramesh, Rebecca Balter, Sandra D Comer, Margaret Haney. Neuropsychopharmacology 2018
67
12





Hot topics in opioid pharmacology: mixed and biased opioids.
Ammar A H Azzam, John McDonald, David G Lambert. Br J Anaesth 2019
69
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.